Hay fever drug to be banned by the FDA.
作者信息
Josefson D
出版信息
BMJ. 1997 Jan 25;314(7076):248. doi: 10.1136/bmj.314.7076.247c.
Abstract
摘要
相似文献
1
Hay fever drug to be banned by the FDA.美国食品药品监督管理局将禁止使用治疗花粉热的药物。
BMJ. 1997 Jan 25;314(7076):248. doi: 10.1136/bmj.314.7076.247c.
2
[Syncopes during simultaneous use of terfenadine and itraconazole].[特非那定与伊曲康唑同时使用时的晕厥]
Ned Tijdschr Geneeskd. 1997 May 10;141(19):950-3.
3
Is 3-mm less drowsiness important?3毫米的嗜睡程度减轻重要吗？
Ann Allergy Asthma Immunol. 2003 Oct;91(4):324-5. doi: 10.1016/S1081-1206(10)61676-6.
4
[Seasonal allergic rhinitis. Nasal obstruction can also beh improved].
MMW Fortschr Med. 2001 May 3;143(18):50.
5
Hypoglycemic effect of terfenadine in patients of allergic rhinitis.特非那定对过敏性鼻炎患者的降血糖作用。
Indian J Physiol Pharmacol. 1996 Apr;40(2):191-2.
6
Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis.富马酸依美斯汀与特非那定治疗季节性变应性鼻炎的疗效和安全性的临床研究
Arzneimittelforschung. 2004;54(10):660-5. doi: 10.1055/s-0031-1297018.
7
First-line treatment of hay fever: what is the best option?花粉热的一线治疗：最佳选择是什么？
CMAJ. 1997 Apr 15;156(8):1141-3.
8
Treatment of hay fever.花粉热的治疗。
J Fam Pract. 1997 Sep;45(3):201.
9
Comparative study of terfenadine and cetirizine in hay fever: assessment of efficacy and central nervous system effects.
J Investig Allergol Clin Immunol. 1995 Jan-Feb;5(1):40-6.
10
Comparative effects of terfenadine and loratadine in the treatment of hay fever.特非那定与氯雷他定治疗花粉症的对比效果
J Investig Allergol Clin Immunol. 1991 Dec;1(6):368-72.
引用本文的文献
1
The importance of matrix in cardiomyogenesis: Defined substrates for maturation and chamber specificity.基质在心肌发生中的重要性：成熟和腔室特异性的特定底物。
Matrix Biol Plus. 2024 Aug 20;24:100160. doi: 10.1016/j.mbplus.2024.100160. eCollection 2024 Dec.
2
Recent Advances in Nanomaterials for Asthma Treatment.纳米材料在哮喘治疗中的最新进展。
Int J Mol Sci. 2022 Nov 20;23(22):14427. doi: 10.3390/ijms232214427.
3
Packaging and Delivery of Asthma Therapeutics.哮喘治疗药物的包装与递送
Pharmaceutics. 2021 Dec 31;14(1):92. doi: 10.3390/pharmaceutics14010092.
4
Transmural and rate-dependent profiling of drug-induced arrhythmogenic risks through in silico simulations of multichannel pharmacology.通过多通道药理学的计算机模拟对药物致心律失常风险进行跨壁和速率依赖性分析。
Sci Rep. 2019 Dec 6;9(1):18504. doi: 10.1038/s41598-019-55032-x.
5
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.模拟多种离子通道阻断可提高对化合物临床致扭风险的早期预测。
Cardiovasc Res. 2011 Jul 1;91(1):53-61. doi: 10.1093/cvr/cvr044. Epub 2011 Feb 7.
6
Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.特非那定与抗抑郁药的相互作用：一项使用人肝微粒体的体外抑制研究。
Br J Clin Pharmacol. 1998 Mar;45(3):318-21. doi: 10.1046/j.1365-2125.1998.00681.x.
7
Antipsychotic agents and QT changes.抗精神病药物与QT间期变化
J Psychiatry Neurosci. 2000 Mar;25(2):154-60.
Zotero 插件